To meet the increasing market demand, ZETA, the biomanufacturing facility design expert, established its North American engineering hub in Greater Philadelphia in August 2021, providing ultra-fast-track project delivery. Today, ZETA USA announced it is well established and actively implementing US-based and multi-national projects for leading pharma and biotech companies.
ZETA has established itself internationally as a one-stop-shop for the biopharmaceutical industry. With ZETA's opening of its new subsidiary in Singapore, Asian companies in the pharmaceutical and biotech industries can now also benefit from customer-specific services on-site.
The ZETA Group has established itself worldwide as a highly competent partner in implementing large-scale biopharmaceutical projects. The sustainable expansion of the team at the Moscow location now makes it possible to offer targeted services for Russian pharmaceutical and biotech companies, particularly in the area of general planning.
The ZETA Group, with 900 highly qualified employees and 14 subsidiaries worldwide, specializes in the design, manufacturing, automation, digitization and qualification of customized biopharmaceutical facilities for aseptic process solutions.
ZETA acts as a one-stop shop, combining plant engineering with HVAC, cleanroom and BMS/EMS design.
ZETA on Tour: International presence at conferences, trade fairs and industry events.
